Vaccine Therapy in Treating Patients With Refractory Metastatic Melanoma

Clinical trial NCT00020397 · COMPLETED

Trial details

NCT number: NCT00020397
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Melanoma (Skin)

Start date: 2000-11-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.